Tetracosactide

Nuvacthen Depot 1MG/ML Suspensión Inyectable

1 mg suspensión inyectableSpainWithdrawnAuthorised 31 Jan 1975

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

SynacthenItaly · Soluzione iniettabile · Alfasigma S.P.A.Same form
Synacthen 0,25 mg/ml, oplossing voor injectie of infusieNetherlands · Oplossing voor injectie of infusie · Alfasigma S.p.A.Same form
Cortrosyn Inj 0.25MGCanada · 0.25 MG / VIAL · Powder For Solution · Amphastar Pharmaceuticals, INC.Same substance
Synacthen DepotCanada · 1 MG / ML · Suspension · Atnahs Pharma UK LimitedSame substance
Synacthen DepotSaudi Arabia · Hafslund Nycomid PharmaSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tetracosactide

Nuvacthen Depot 1MG/ML Suspensión Inyectable

1 mg suspensión inyectableSpainWithdrawnAuthorised 31 Jan 1975

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Synacthen Depot

Saudi Arabia · TAKEDA AUSTRIA GmbH

Packs

Pack	Code	Status
NUVACTHEN DEPOT 1MG/ML SUSPENSIÓN INYECTABLE , 3 ampollas de 1 ml	700584

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tetracosactide
Strength: 1 mg
Dosage form: suspensión inyectable
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 31 Jan 1975
Registration: 46454
Marketing authorisation holder: Alfasigma S.P.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica